Literature DB >> 24614156

Acute wounding alters the beta2-adrenergic signaling and catecholamine synthetic pathways in keratinocytes.

Raja K Sivamani1, Biao Shi2, Elizabeth Griffiths2, Shirley M Vu2, Hadar A Lev-Tov3, Sara Dahle4, Marianne Chigbrow2, Thi Dinh La2, Chelcy Mashburn5, Thomas R Peavy5, R Rivkah Isseroff6.   

Abstract

Keratinocyte migration is critical for wound re-epithelialization. Previous studies showed that epinephrine activates the beta2-adrenergic receptor (B2AR), impairing keratinocyte migration. Here, we investigated the keratinocyte catecholamine synthetic pathway in response to acute trauma. Cultured keratinocytes were scratch wounded and expression levels of the B2AR and catecholamine synthetic enzymes tyrosine hydroxylase and phenylethanolamine-N-methyltransferase were assayed. The binding affinity of the B2AR was measured. Wounding downregulated B2AR, tyrosine hydroxylase, and phenylethanolamine-N-methyltransferase expression, but pre-exposure to timolol, a beta-adrenergic receptor antagonist, delayed this effect. In wounded keratinocytes, B2AR-binding affinity remained depressed even after its expression returned to prewounding levels. Keratinocyte-derived norepinephrine increased after wounding. Norepinephrine impaired keratinocyte migration; this effect was abrogated with B2AR-selective antagonist ICI-118,551 but not with B1AR-selective antagonist bisoprolol. Finally, for clinical relevance, we determined that norepinephrine was present in freshly wounded skin, thus providing a potential mechanism for impaired healing by local B2AR activation in wound-edge keratinocytes. Taken together, the data show that keratinocytes modulate catecholamine synthetic enzymes and release norepinephrine after scratch wounding. Norepinephrine appears to be a stress-related mediator that impairs keratinocyte migration through activation of the B2AR. Future therapeutic strategies evaluating modulation of norepinephrine-related effects in the wound are warranted.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24614156     DOI: 10.1038/jid.2014.137

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  58 in total

1.  High density of beta 2-adrenoceptors in a human keratinocyte cell line with complete epidermal differentiation capacity (HaCaT).

Authors:  V Steinkraus; C Körner; M Steinfath; H Mensing
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

2.  An epinephrine-dependent mechanism for the control of UV-induced pigmentation.

Authors:  Raja K Sivamani; Scott M Porter; R Rivkah Isseroff
Journal:  J Invest Dermatol       Date:  2008-08-21       Impact factor: 8.551

3.  Ultraviolet radiation augments epidermal beta-adrenergic adenylate cyclase response.

Authors:  H Iizuka; S Kajita; A Ohkawara
Journal:  J Invest Dermatol       Date:  1985-05       Impact factor: 8.551

4.  FGF receptors 1 and 2 are key regulators of keratinocyte migration in vitro and in wounded skin.

Authors:  Michael Meyer; Anna-Katharina Müller; Jingxuan Yang; Daniel Moik; Gilles Ponzio; David M Ornitz; Richard Grose; Sabine Werner
Journal:  J Cell Sci       Date:  2012-09-19       Impact factor: 5.285

5.  Short chain fatty acids regulate tyrosine hydroxylase gene expression through a cAMP-dependent signaling pathway.

Authors:  Manuel DeCastro; Bistra B Nankova; Parul Shah; Pranav Patel; Pradeep V Mally; Ravi Mishra; Edmund F La Gamma
Journal:  Brain Res Mol Brain Res       Date:  2005-10-10

6.  Dynamic changes in intracellular localization and isoforms of the 27-kD stress protein in human keratinocytes.

Authors:  M McClaren; R R Isseroff
Journal:  J Invest Dermatol       Date:  1994-03       Impact factor: 8.551

7.  Differential signaling of the endogenous agonists at the beta2-adrenergic receptor.

Authors:  Susanne Reiner; Manuela Ambrosio; Carsten Hoffmann; Martin J Lohse
Journal:  J Biol Chem       Date:  2010-09-13       Impact factor: 5.157

Review 8.  Molecular mechanisms of beta(2)-adrenergic receptor function, response, and regulation.

Authors:  Malcolm Johnson
Journal:  J Allergy Clin Immunol       Date:  2006-01       Impact factor: 10.793

9.  Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin.

Authors:  S K Shenoy; P H McDonald; T A Kohout; R J Lefkowitz
Journal:  Science       Date:  2001-10-04       Impact factor: 47.728

10.  Norepinephrine- and epinephrine-induced distinct beta2-adrenoceptor signaling is dictated by GRK2 phosphorylation in cardiomyocytes.

Authors:  Yongyu Wang; Vania De Arcangelis; Xiaoguang Gao; Biswarathan Ramani; Yi-sook Jung; Yang Xiang
Journal:  J Biol Chem       Date:  2007-12-03       Impact factor: 5.157

View more
  9 in total

1.  Systems biology of facial development: contributions of ectoderm and mesenchyme.

Authors:  Joan E Hooper; Weiguo Feng; Hong Li; Sonia M Leach; Tzulip Phang; Charlotte Siska; Kenneth L Jones; Richard A Spritz; Lawrence E Hunter; Trevor Williams
Journal:  Dev Biol       Date:  2017-03-29       Impact factor: 3.582

2.  Absorption and Safety of Topically Applied Timolol for Treatment of Chronic Cutaneous Wounds.

Authors:  Anthony Cole Gallegos; Michael James Davis; Catherine N Tchanque-Fossuo; Kaitlyn West; Angela Eisentrout-Melton; Thomas R Peavy; Roy W Dixon; Roma P Patel; Sara Evona Dahle; Roslyn Rivkah Isseroff
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-10-16       Impact factor: 4.730

3.  The Beta 2 Adrenergic Receptor Antagonist Timolol Improves Healing of Combined Burn and Radiation Wounds.

Authors:  Huguette Albrecht; Hsin-Ya Yang; Maija Kiuru; Saipiroon Maksaereekul; Blythe Durbin-Johnson; Michael S Wong; Thomas R Stevenson; David M Rocke; R Rivkah Isseroff
Journal:  Radiat Res       Date:  2018-01-26       Impact factor: 2.841

Review 4.  Repurposing Ophthalmologic Timolol for Dermatologic Use: Caveats and Historical Review of Adverse Events.

Authors:  Daniel J Yoon; Ramanjot Kaur; Anthony Gallegos; Kaitlyn West; Hsinya Yang; Saul Schaefer; Catherine Tchanque-Fossuo; Sara E Dahle; R Rivkah Isseroff
Journal:  Am J Clin Dermatol       Date:  2020-11-25       Impact factor: 7.403

Review 5.  [Mechanisms of adrenergic β-antagonist for wounds and its application prospect in diabetic foot ulcers].

Authors:  Shiyi Sun; Jing Ma; Xingwu Ran
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-12-15

6.  Prolactin may serve as a regulator to promote vocal fold wound healing.

Authors:  Haizhou Wang; Xueyan Li; Jieyu Lu; Paul Jones; Wen Xu
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

7.  Carvedilol, an Adrenergic Blocker, Suppresses Melanin Synthesis by Inhibiting the cAMP/CREB Signaling Pathway in Human Melanocytes and Ex Vivo Human Skin Culture.

Authors:  Myoung Eun Choi; Hanju Yoo; Ha-Ri Lee; Ik Joon Moon; Woo Jin Lee; Youngsup Song; Sung Eun Chang
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

8.  Alpha and beta adrenergic receptors modulate keratinocyte migration.

Authors:  Hsin-Ya Yang; Pieter Steenhuis; Aaron M Glucksman; Zhanna Gurenko; Thi Dinh La; R Rivkah Isseroff
Journal:  PLoS One       Date:  2021-07-02       Impact factor: 3.240

9.  Beta-adrenergic antagonist for the healing of chronic diabetic foot ulcers: study protocol for a prospective, randomized, double-blinded, controlled and parallel-group study.

Authors:  Ramanjot Kaur; Catherine Tchanque-Fossuo; Kaitlyn West; Yasmin Hadian; Anthony Gallegos; Daniel Yoon; Ligia Ismailyan; Saul Schaefer; Sara E Dahle; R Rivkah Isseroff
Journal:  Trials       Date:  2020-06-08       Impact factor: 2.279

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.